Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wan-Teck Lim

Showing results (121-130 of 137) with videos related to

Pageof 14
Sort By:
Lung Cancer (Amsterdam, Netherlands)|December 14, 2019
Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysisAaron C Tan, Gillianne G Y Lai, Gek San Tan, et al.
Nature Communications|January 17, 2018
Elucidating the genomic architecture of Asian EGFR-mutant lung adenocarcinoma through multi-region exome sequencingRahul Nahar, Weiwei Zhai, Tong Zhang, et al.
Oncotarget|May 4, 2017
A systematic review and meta-analysis of individual patient data on the impact of the BIM deletion polymorphism on treatment outcomes in epidermal growth factor receptor mutant lung cancerSheila X Soh, Fahad J Siddiqui, John C Allen, et al.
Thyroid : Official Journal of the American Thyroid Association|June 16, 2020
An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid CancerKeith C Bible, Michael E Menefee, Chia-Chi Josh Lin, et al.
Nature|May 18, 2018
Bystander CD8<sup>+</sup> T cells are abundant and phenotypically distinct in human tumour infiltratesYannick Simoni, Etienne Becht, Michael Fehlings, et al.
International Journal of Molecular Sciences|March 13, 2025
Cell Migration in Endometriosis Responds to Omentum-Derived Molecular Cues Similar to Ovarian CancerKah Yee Goh, Su Chin Tham, Terence You De Cheng, et al.
JCO Precision Oncology|July 12, 2021
Individualized Molecular Profiling for Allocation to Clinical Trials Singapore Study-An Asian Tertiary Cancer Center ExperienceAmanda O L Seet, Aaron C Tan, Tira J Tan, et al.
Nature Medicine|August 3, 2021
Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trialHai-Qiang Mai, Qiu-Yan Chen, Dongping Chen, et al.
JTO Clinical and Research Reports|November 25, 2022
A Randomized Phase 2 Trial of Nivolumab Versus Nivolumab-Ipilimumab Combination in EGFR-Mutant NSCLCGillianne G Y Lai, Jia Chi Yeo, Amit Jain, et al.
JAMA|November 28, 2023
Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: The JUPITER-02 Randomized Clinical TrialHai-Qiang Mai, Qiu-Yan Chen, Dongping Chen, et al.
Pageof 14

Showing results (121-130 of 137) with videos related to

Sort By:
Pageof 14
Lung Cancer (Amsterdam, Netherlands)|December 14, 2019
Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysisAaron C Tan, Gillianne G Y Lai, Gek San Tan, et al.
Nature Communications|January 17, 2018
Elucidating the genomic architecture of Asian EGFR-mutant lung adenocarcinoma through multi-region exome sequencingRahul Nahar, Weiwei Zhai, Tong Zhang, et al.
Oncotarget|May 4, 2017
A systematic review and meta-analysis of individual patient data on the impact of the BIM deletion polymorphism on treatment outcomes in epidermal growth factor receptor mutant lung cancerSheila X Soh, Fahad J Siddiqui, John C Allen, et al.
Thyroid : Official Journal of the American Thyroid Association|June 16, 2020
An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid CancerKeith C Bible, Michael E Menefee, Chia-Chi Josh Lin, et al.
Nature|May 18, 2018
Bystander CD8<sup>+</sup> T cells are abundant and phenotypically distinct in human tumour infiltratesYannick Simoni, Etienne Becht, Michael Fehlings, et al.
International Journal of Molecular Sciences|March 13, 2025
Cell Migration in Endometriosis Responds to Omentum-Derived Molecular Cues Similar to Ovarian CancerKah Yee Goh, Su Chin Tham, Terence You De Cheng, et al.
JCO Precision Oncology|July 12, 2021
Individualized Molecular Profiling for Allocation to Clinical Trials Singapore Study-An Asian Tertiary Cancer Center ExperienceAmanda O L Seet, Aaron C Tan, Tira J Tan, et al.
Nature Medicine|August 3, 2021
Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trialHai-Qiang Mai, Qiu-Yan Chen, Dongping Chen, et al.
JTO Clinical and Research Reports|November 25, 2022
A Randomized Phase 2 Trial of Nivolumab Versus Nivolumab-Ipilimumab Combination in EGFR-Mutant NSCLCGillianne G Y Lai, Jia Chi Yeo, Amit Jain, et al.
JAMA|November 28, 2023
Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: The JUPITER-02 Randomized Clinical TrialHai-Qiang Mai, Qiu-Yan Chen, Dongping Chen, et al.
Pageof 14